Amikacin (Inhalation)

DRUG2 trials

Sponsors

Postgraduate Medical Institute, Lahore, The University of Queensland

Conditions

Mycobacterium Abscessus InfectionMycobacterium Abscessus Pulmonary DiseaseNon-Tuberculous Mycobacteria Pulmonary DiseaseNon-Tuberculous Mycobacterial (NTM) InfectionsVentilator Associated Pneumonia ( VAP)

Phase 2

Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial

Not yet recruitingNCT07485010

The University of QueenslandMycobacterium Abscessus Infection, Mycobacterium Abscessus Pulmonary Disease, Non-Tuberculous Mycobacterial (NTM) Infections +1

Start: 2027-04-01End: 2031-07-01Target: 300Updated: 2026-03-20

Phase 4

Clinical Outcomes of Inhaled Amikacin in Ventilator Associated Pneumonia

CompletedNCT07369336

Postgraduate Medical Institute, LahoreVentilator Associated Pneumonia ( VAP)

Start: 2024-01-05End: 2025-09-30Updated: 2026-01-27